{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T02:15:07Z","timestamp":1768616107643,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2021QH1075"],"award-info":[{"award-number":["2021QH1075"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112623","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:32:16Z","timestamp":1720571536000},"page":"112623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer"],"prefix":"10.1016","volume":"138","author":[{"given":"Zhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Ming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Zhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Yi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Shui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2024.112623_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.intimp.2024.112623_b0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","article-title":"What Is the Significance of Variant Histology in Urothelial Carcinoma?","volume":"6","author":"Lobo","year":"2020","journal-title":"Eur. Urol.Focus"},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejca.2005.08.032","article-title":"Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours","volume":"42","author":"Sternberg","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2024.112623_b0020","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.intimp.2024.112623_b0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0030","first-page":"11","article-title":"Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer","volume":"33","author":"Alhalabi","year":"2019","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"10.1016\/j.intimp.2024.112623_b0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response","volume":"40","author":"Kroemer","year":"2010","journal-title":"Mol. Cell"},{"issue":"16","key":"10.1016\/j.intimp.2024.112623_b0040","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMra2022774","article-title":"Autophagy in Human Diseases","volume":"383","author":"Mizushima","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2024.112623_b0050","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.juro.2014.01.006","article-title":"Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent","volume":"191","author":"Ojha","year":"2014","journal-title":"J. Urol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112623_b0055","doi-asserted-by":"crossref","first-page":"1801927","DOI":"10.1002\/advs.201801927","article-title":"ATG7 Promotes Bladder Cancer Invasion via Autophagy-Mediated Increased ARHGDIB mRNA Stability","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv Sci (weinh)"},{"issue":"6","key":"10.1016\/j.intimp.2024.112623_b0060","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1007\/s13277-015-4410-2","article-title":"Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy","volume":"37","author":"Shen","year":"2016","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112623_b0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/auto.8.2.18554","article-title":"Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy","volume":"8","author":"Maycotte","year":"2012","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000486222","article-title":"Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis","volume":"45","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2024.112623_b0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.gpb.2022.08.004","article-title":"TIGER: A Web Portal of Tumor Immunotherapy Gene Expression Resource","volume":"21","author":"Chen","year":"2023","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.intimp.2024.112623_b0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2024.112623_b0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2024.112623_b0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.112623_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.intimp.2024.112623_b0105","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.112623_b0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2024.112623_b0120","first-page":"6","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","author":"Racle","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2024.112623_b0125","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2024.112623_b0130","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa164","article-title":"Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology","volume":"22","author":"Yang","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.intimp.2024.112623_b0135","first-page":"11","article-title":"A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer","author":"Yang","year":"2022","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbv020","article-title":"Lu Z: A survey of current trends in computational drug repositioning","volume":"17","author":"Li","year":"2016","journal-title":"Brief. Bioinform."},{"issue":"6","key":"10.1016\/j.intimp.2024.112623_b0145","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab260","article-title":"Huang RS: oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"3","key":"10.1016\/j.intimp.2024.112623_b0150","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/gb-2014-15-3-r47","article-title":"Clinical drug response can be predicted using baseline gene expression and in vitro drug sensitivity in cell lines","volume":"15","author":"Geeleher","year":"2014","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112623_b0155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.eururo.2004.04.001","article-title":"Metastasis markers in bladder cancer: a review of the literature and clinical considerations","volume":"46","author":"Gontero","year":"2004","journal-title":"Eur. Urol."},{"key":"10.1016\/j.intimp.2024.112623_b0160","article-title":"Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112623_b0165","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.omtn.2022.01.018","article-title":"Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with UCEC","volume":"27","author":"Liu","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.intimp.2024.112623_b0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.addr.2020.12.003","article-title":"Autophagy in the cancer-immunity dialogue","volume":"169","author":"Yamazaki","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2024.112623_b0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.canlet.2013.06.009","article-title":"Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy","volume":"339","author":"Wu","year":"2013","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.112623_b0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","article-title":"T follicular helper cells in cancer","volume":"9","author":"Guti\u00e9rrez-Melo","year":"2023","journal-title":"Trends Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2024.112623_b0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2024.112623_b0190","doi-asserted-by":"crossref","unstructured":"Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I: CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. International journal of molecular sciences 2020, 21(20).","DOI":"10.3390\/ijms21207619"},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","article-title":"Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets","volume":"15","author":"Tie","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112623_b0200","doi-asserted-by":"crossref","first-page":"e2205613","DOI":"10.1002\/advs.202205613","article-title":"ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci (weinh)"},{"issue":"6","key":"10.1016\/j.intimp.2024.112623_b0205","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"20","key":"10.1016\/j.intimp.2024.112623_b0210","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1039\/D0BM01183E","article-title":"Immunostimulatory biomaterials to boost tumor immunogenicity","volume":"8","author":"Shofolawe-Bakare","year":"2020","journal-title":"Biomater. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2024.112623_b0215","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.18632\/aging.103050","article-title":"Identification of UAP1L1 as tumor promotor in gastric cancer through regulation of CDK6","volume":"12","author":"Qi","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12967-022-03291-0","article-title":"Identification of UAP1L1 as a critical factor for prostate cancer and underlying molecular mechanism in tumorigenicity","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112623_b0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mc.23278","article-title":"Silencing of UAP1L1 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma","volume":"60","author":"Xiao","year":"2021","journal-title":"Mol. Carcinog."},{"issue":"9","key":"10.1016\/j.intimp.2024.112623_b0230","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/1878-0261.12532","article-title":"Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target","volume":"13","author":"Yamada","year":"2019","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112623_b0235","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11010-021-04289-w","article-title":"PLOD1 acts as a tumor promoter in glioma via activation of the HSF1 signaling pathway","volume":"477","author":"Yuan","year":"2022","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2024.112623_b0240","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/onc.2016.227","article-title":"Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization","volume":"36","author":"Cai","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010062","article-title":"The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer","volume":"13","author":"Ma","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.intimp.2024.112623_b0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-020-1541-0","article-title":"FKBP9 promotes the malignant behavior of glioblastoma cells and confers resistance to endoplasmic reticulum stress inducers","volume":"39","author":"Xu","year":"2020","journal-title":"Journal of Experimental & Clinical Cancer Research : CR"},{"issue":"8","key":"10.1016\/j.intimp.2024.112623_b0255","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrd3184","article-title":"Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy","volume":"9","author":"Strebhardt","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.intimp.2024.112623_b0260","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/cbt.25087","article-title":"Francisco de Oliveira H, Scrideli CA, Tone LG: In vitro targeting of Polo-like kinase 1 in bladder carcinoma: comparative effects of four potent inhibitors","volume":"14","author":"Brassesco","year":"2013","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2024.112623_b0265","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/jcmm.13018","article-title":"Targeted inhibition of Polo-like kinase 1 by a novel small-molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells","volume":"21","author":"Zhang","year":"2017","journal-title":"J. Cell Mol. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:37:17Z","timestamp":1722361037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924011445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":53,"alternative-id":["S1567576924011445"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112623","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112623","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112623"}}